Return to Emergent BioSolutions

    Winnipeg

    Manitoba, Canada

    Emergent CDMO Sites

    At-a-Glance

    For more than 30 years, our site in Winnipeg, Manitoba (Canada), has offered clients a broad range of expertise for drug substance and drug product manufacturing. The 150,000-sq .ft. facility manufactures polyclonal hyperimmune products (including six licensed by the FDA and Health Canada) as well as plasma therapeutics, lipoproteins, and mRNA products. Our Winnipeg team has the capacity, experience, and drive to customize manufacturing suites to support client-driven complex process requirements and infrastructure.

    Manufacturing Capabilities and Technologies

    Five Manufacturing Areas

    • Small-scale manufacturing area
    • Large-scale manufacturing area
    • Large-scale manufacturing  &  large scale (up to 1,000L) human hyperimmune manufacturing area
    • Large-scale (up to 1000L) equine hyperimmune manufacturing area
    • Bulk product formulation area
    Aseptic Fill/Finish
    • SA25 aseptic isolator filling line for clinical and small-volume commercial products 

    Packaging

    • Visual inspection
    • Packaging & labeling
    • Warehouse
    • Onsite cold temperature storage

    Download Cytiva SA25 Fact Sheet

    Would you like to visit our Winnipeg site?

    Request A Tour

    Request A Tour

    Thank you for your interest in touring our sites! Please complete this form and a member of our Customer Experience Team will connect with you to discuss touring options for this and other EBSI manufacturing sites.